ABR-215050

· Active Biotech AB

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABR-215050, covering 2014-08-27 to 2015-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of ABR-215050 to Treat Prostate Cancer [Phase 2]